Avita Medical (RCEL) Trading Activity
Avita Medical (ticker RCEL) recorded a flat movement of 0 % during the 24‑hour period ending at 05:22 AM Central Europe on Thursday, 22 October 2026.
| Item | Value |
|---|---|
| Current share price | USD 15.29 |
| Shares outstanding | 30.9 million |
| Market capitalization | USD 403.3 million |
| 24‑hour volume | USD 5.8 million |
| Month‑end change | +27.31 % |
| 200‑day simple moving average | USD 7.81 |
| 52‑week high | USD 14.08 (20 October 2026) |
| 52‑week low | USD 3.22 (7 January 2026) |
24‑Hour Performance of Related Stocks
| Company | Ticker | 24‑Hour Change | Current Price | Market Cap |
|---|---|---|---|---|
| B&r Merger | BRTMU | –0.30 % | USD 10.57 | USD 477.2 million |
| Aquestive Therapeutics | AQST | +5.74 % | USD 4.08 | USD 480.7 million |
| Monopar Therapeutics | MNPR | +3.86 % | USD 72.35 | USD 479.7 million |
| Angiodynamics | ANGO | +3.69 % | USD 11.89 | USD 479.0 million |
| Neurogene | NGNE | +5.09 % | USD 26.08 | USD 483.7 million |
Company Overview
Avita Medical, Inc. is a healthcare biotechnology company that develops and commercializes therapies for patients with burns, chronic wounds, and aesthetic indications worldwide.
